{
    "Project Title": "Post-resection/ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 \u2013 PORT / AIO-KRK-0418)",
    "Sponsor": "Charit\u00e9 Universit\u00e4tsmedizin Berlin",
    "Study Number": "AIO-KRK-0418",
    "Protocol Version and Date": "Version 3.0 dated 28-Sep-2021",
    "Study Title": "Post-resection/ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 \u2013 PORT / AIO-KRK-0418)",
    "Phase": "Phase III",
    "Therapeutic Area": "Metastatic colorectal cancer",
    "Number of Patients": "507",
    "Number of Sites": "About 80",
    "Indication": "Post-resection/ablation chemotherapy in patients with metastatic colorectal cancer",
    "Duration of Treatment": "6 months",
    "Schedule of Assessments": "Section 6.1.2, Table 1",
    "questionnaires": [
        {
            "longName": "EQ5D5L Questionnaire",
            "shortName": "EQ5D5L",
            "type": "PRO",
            "questionnaireSchedule": "Every 3 months during the first 24 months after randomization, and every 6 months afterwards for up to 60 months."
        },
        {
            "longName": "Carcinoembryonic antigen",
            "shortName": "CEA",
            "type": "ClinRO",
            "questionnaireSchedule": "Every 3 months during the first 24 months after randomization, and every 6 months afterwards for up to 60 months."
        },
        {
            "longName": "Tumor Imaging",
            "shortName": "Tumor Imaging",
            "type": "ClinRO",
            "questionnaireSchedule": "Every 3 months during the first 24 months after randomization, and every 6 months thereafter."
        },
        {
            "longName": "ECOG Performance Status",
            "shortName": "ECOG",
            "type": "ClinRO",
            "questionnaireSchedule": "At screening and every three months thereafter for the first 2 years after randomization."
        }
    ]
}